Pub Date : 2024-10-05DOI: 10.1016/j.jcjo.2024.09.002
Mostafa Bondok, Anne Xuan-Lan Nguyen, Stuti M Tanya, Gun Min Youn, Leonardo Lando, Albert Y Wu
Objective: To determine the characteristics associated with higher online ratings of academic ophthalmologists in Canada.
Design: Retrospective cross-sectional study.
Methods: All ophthalmologists affiliated with Canadian ophthalmology departments were queried in March 2023 using WebMDs. Online ratings and physician profile details were extracted and descriptively analyzed using nonparametric tests with significance at p < 0.05. Subgroup analysis was conducted using ≥ 4-star rated profiles.
Results: Eight hundred and ninety-nine department faculty from 15 institutions were considered, and 660 ophthalmologists with active, rated profiles were included. A total of 27,823 online ratings with a median of 4.14 stars (out of 5) were observed. Most profiles were of men (74.1%). Women received lower overall ratings compared to men (median = 4.08 vs. 4.20; p = 0.021), and lower number of reviews (median = 23 vs. 34; p < 0.001). Most profiles included office addresses (87.9%), private practice affiliation (79.8%), and contact information (51.1%). There was a positive correlations between higher ratings and profiles that included biographies (rho = 0.13; p = 0.001), languages spoken (rho = 0.15; p < 0.001), educational background (rho = 0.13; p < 0.001), areas of expertise (rho = 0.10; p = 0.010), awards (rho = 0.12; p = 0.002), and among physicians indicating they accept new patients (rho = 0.15; p < 0.001) and accommodate virtual visits (rho = 0.09; p = 0.020).
Conclusions: Canadian ophthalmologists having certain personal information on their online profiles tended to have higher ratings, despite weak associations, possibly due to wider public outreach. Women had fewer and lower overall ratings compared to men. Further research about online ratings' influence on physician selection and physician career satisfaction is needed.
{"title":"Gender and personalized profile information influence online ratings of Canadian academic ophthalmologists.","authors":"Mostafa Bondok, Anne Xuan-Lan Nguyen, Stuti M Tanya, Gun Min Youn, Leonardo Lando, Albert Y Wu","doi":"10.1016/j.jcjo.2024.09.002","DOIUrl":"10.1016/j.jcjo.2024.09.002","url":null,"abstract":"<p><strong>Objective: </strong>To determine the characteristics associated with higher online ratings of academic ophthalmologists in Canada.</p><p><strong>Design: </strong>Retrospective cross-sectional study.</p><p><strong>Methods: </strong>All ophthalmologists affiliated with Canadian ophthalmology departments were queried in March 2023 using WebMDs. Online ratings and physician profile details were extracted and descriptively analyzed using nonparametric tests with significance at p < 0.05. Subgroup analysis was conducted using ≥ 4-star rated profiles.</p><p><strong>Results: </strong>Eight hundred and ninety-nine department faculty from 15 institutions were considered, and 660 ophthalmologists with active, rated profiles were included. A total of 27,823 online ratings with a median of 4.14 stars (out of 5) were observed. Most profiles were of men (74.1%). Women received lower overall ratings compared to men (median = 4.08 vs. 4.20; p = 0.021), and lower number of reviews (median = 23 vs. 34; p < 0.001). Most profiles included office addresses (87.9%), private practice affiliation (79.8%), and contact information (51.1%). There was a positive correlations between higher ratings and profiles that included biographies (rho = 0.13; p = 0.001), languages spoken (rho = 0.15; p < 0.001), educational background (rho = 0.13; p < 0.001), areas of expertise (rho = 0.10; p = 0.010), awards (rho = 0.12; p = 0.002), and among physicians indicating they accept new patients (rho = 0.15; p < 0.001) and accommodate virtual visits (rho = 0.09; p = 0.020).</p><p><strong>Conclusions: </strong>Canadian ophthalmologists having certain personal information on their online profiles tended to have higher ratings, despite weak associations, possibly due to wider public outreach. Women had fewer and lower overall ratings compared to men. Further research about online ratings' influence on physician selection and physician career satisfaction is needed.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-02DOI: 10.1016/j.jcjo.2024.09.004
Jessica J Waninger, F Yesim Demirci, Hakan Demirci
Objective: Conjunctival melanoma (CJM) is a rare subtype of mucosal melanomas. Despite an increasing understanding of CJM genetics, predicting patient prognosis remains challenging. Here we sought to see if a 31-gene expression profile (31-GEP) test (i.e., DecisionDx-Melanoma) originally developed and validated for cutaneous melanoma (CM) could be useful in the prognostication of patients with CJM.
Design/participants: We performed a single-center retrospective review and gene expression profiling of 10 patients with CJM.
Methods: Deidentified archived samples of each primary tumor were sent to Castle Biosciences, where 31-GEP testing was performed. Patients were followed until death or a minimum of 5 years postexcision and monitored for tumor recurrence or metastatic spread. Mean fold change in individual gene expression was compared between nonmetastatic and metastatic groups via independent t-tests.
Results: Fifty percent of patients developed metastatic disease and had reduced overall survival (3.6 vs 9.3 months; p = 0.018). In 4 of 10 patients, two nonmetastatic and two metastatic, tumor samples passed Castle Biosciences quality control allowing for class designation. All metastatic patients and one nonmetastatic patient were designated as class 2B. The final nonmetastatic patient was designated as class 1B. In individual gene analysis, BAP1 expression was significantly reduced in the metastatic group (p = 0.03).
Conclusions: In assessing if a CM gene expression panel could aid in the risk stratification of patients with CJM, we found that the uveal melanoma-relevant gene, BAP1, may be important. Additional studies with larger sample sizes are needed to determine the relevance of this and other differentially expressed genes in CJM prognostication.
{"title":"Genetic analysis of metastatic versus nonmetastatic conjunctival melanoma using a cutaneous melanoma gene expression panel.","authors":"Jessica J Waninger, F Yesim Demirci, Hakan Demirci","doi":"10.1016/j.jcjo.2024.09.004","DOIUrl":"10.1016/j.jcjo.2024.09.004","url":null,"abstract":"<p><strong>Objective: </strong>Conjunctival melanoma (CJM) is a rare subtype of mucosal melanomas. Despite an increasing understanding of CJM genetics, predicting patient prognosis remains challenging. Here we sought to see if a 31-gene expression profile (31-GEP) test (i.e., DecisionDx-Melanoma) originally developed and validated for cutaneous melanoma (CM) could be useful in the prognostication of patients with CJM.</p><p><strong>Design/participants: </strong>We performed a single-center retrospective review and gene expression profiling of 10 patients with CJM.</p><p><strong>Methods: </strong>Deidentified archived samples of each primary tumor were sent to Castle Biosciences, where 31-GEP testing was performed. Patients were followed until death or a minimum of 5 years postexcision and monitored for tumor recurrence or metastatic spread. Mean fold change in individual gene expression was compared between nonmetastatic and metastatic groups via independent t-tests.</p><p><strong>Results: </strong>Fifty percent of patients developed metastatic disease and had reduced overall survival (3.6 vs 9.3 months; p = 0.018). In 4 of 10 patients, two nonmetastatic and two metastatic, tumor samples passed Castle Biosciences quality control allowing for class designation. All metastatic patients and one nonmetastatic patient were designated as class 2B. The final nonmetastatic patient was designated as class 1B. In individual gene analysis, BAP1 expression was significantly reduced in the metastatic group (p = 0.03).</p><p><strong>Conclusions: </strong>In assessing if a CM gene expression panel could aid in the risk stratification of patients with CJM, we found that the uveal melanoma-relevant gene, BAP1, may be important. Additional studies with larger sample sizes are needed to determine the relevance of this and other differentially expressed genes in CJM prognostication.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01DOI: 10.1016/j.jcjo.2024.09.003
Swathi Kaliki, Vijitha S Vempuluru, Vishakha Tanna, Anshika Luthra
Objective: To analyze factors predictive of tumor recurrence, orbital exenteration, lymph node metastasis, systemic metastasis, and metastasis-related death in patients with eyelid and periocular sebaceous gland carcinoma (eSGC) undergoing protocol-based management.
Methods: Retrospective interventional study RESULTS: Of the 355 patients with eSGC, 248 (70%) were referred to us without any prior intervention, and 107 (30%) had a history of prior intervention. The treatment modalities after presentation to our center included excisional biopsy (n = 303, 85%), orbital exenteration (n = 36, 85%), neoadjuvant chemotherapy (n = 12, 3%), and topical mitomycin C (n = 4, 1%). The 15-year Kaplan Meier estimates of tumor recurrence, need for orbital exenteration, lymph node metastasis, systemic metastasis, and metastasis-related death were 23%, 26%, 12%, 8%, and 9%, respectively. Multivariate Cox regression model identified positive histopathological margins (p < 0.001) and perivascular invasion (p < 0.001) as predictors of tumor recurrence; diffuse tumor morphology (p = 0.009), tumor diameter >20 mm (p = 0.027), orbital extension of the tumor (p < 0.001), perivascular invasion (p = 0.013), and pagetoid tumor spread (p < 0.001) on histopathology as predictors of orbital exenteration; diffuse tumor morphology (p = 0.005), tumor diameter >10 mm (p = 0.015), and perivascular invasion (p = 0.008) as predictors of lymph node metastasis; diffuse tumor morphology (p = 0.024) as a predictor of systemic metastasis; and multicentric tumor origin (p = 0.035) as a predictor of metastasis-related death.
Conclusion: Clinical features, including diffuse tumor morphology, multicentric tumor origin, larger tumor diameter, and orbital extension of the tumor, and histopathological features, including pagetoid tumor spread, positive histopathological margins, and perivascular invasion, are predictors of poor outcomes in eSGC.
{"title":"Eyelid and periocular sebaceous gland carcinoma: risk factors for recurrence, exenteration, metastasis, and death in 355 patients.","authors":"Swathi Kaliki, Vijitha S Vempuluru, Vishakha Tanna, Anshika Luthra","doi":"10.1016/j.jcjo.2024.09.003","DOIUrl":"10.1016/j.jcjo.2024.09.003","url":null,"abstract":"<p><strong>Objective: </strong>To analyze factors predictive of tumor recurrence, orbital exenteration, lymph node metastasis, systemic metastasis, and metastasis-related death in patients with eyelid and periocular sebaceous gland carcinoma (eSGC) undergoing protocol-based management.</p><p><strong>Methods: </strong>Retrospective interventional study RESULTS: Of the 355 patients with eSGC, 248 (70%) were referred to us without any prior intervention, and 107 (30%) had a history of prior intervention. The treatment modalities after presentation to our center included excisional biopsy (n = 303, 85%), orbital exenteration (n = 36, 85%), neoadjuvant chemotherapy (n = 12, 3%), and topical mitomycin C (n = 4, 1%). The 15-year Kaplan Meier estimates of tumor recurrence, need for orbital exenteration, lymph node metastasis, systemic metastasis, and metastasis-related death were 23%, 26%, 12%, 8%, and 9%, respectively. Multivariate Cox regression model identified positive histopathological margins (p < 0.001) and perivascular invasion (p < 0.001) as predictors of tumor recurrence; diffuse tumor morphology (p = 0.009), tumor diameter >20 mm (p = 0.027), orbital extension of the tumor (p < 0.001), perivascular invasion (p = 0.013), and pagetoid tumor spread (p < 0.001) on histopathology as predictors of orbital exenteration; diffuse tumor morphology (p = 0.005), tumor diameter >10 mm (p = 0.015), and perivascular invasion (p = 0.008) as predictors of lymph node metastasis; diffuse tumor morphology (p = 0.024) as a predictor of systemic metastasis; and multicentric tumor origin (p = 0.035) as a predictor of metastasis-related death.</p><p><strong>Conclusion: </strong>Clinical features, including diffuse tumor morphology, multicentric tumor origin, larger tumor diameter, and orbital extension of the tumor, and histopathological features, including pagetoid tumor spread, positive histopathological margins, and perivascular invasion, are predictors of poor outcomes in eSGC.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-20DOI: 10.1016/j.jcjo.2024.08.016
Ya-Ping Jin, Kiko Zi Yi Huang, Qingqing K Zhao, Graham E Trope, Yvonne M Buys, Sherif El-Defrawy, Peng Yan, Michael H Brent, Ziad Butty
Objective: To estimate the prevalence of glaucoma in Canada based on self-reports and test data, including Frequency Doubling Technology Perimetry (FDT), optic nerve vertical cup-to-disc ratio (CDR), intraocular pressure (IOP), and use of glaucoma medications.
Design: Cross-sectional survey.
Participants: 2,600-4,100 participants aged 40-79 in the Canadian Health Measures Survey 2016-2019 with available information from self-report, CDR, FDT, and IOP.
Methods: Glaucoma was defined by self-reports, CDR ≥ 0.7 only, or failed FDT only. Incorporating results of CDR, FDT, IOP, and use of glaucoma medications, participants were further classified as definite glaucoma (failed FDT and CDR ≥ 0.7) or glaucoma suspects (CDR ≥ 0.7 only, failed FDT only, or IOP > 21 mmHg only, or "normal" values of FDT, CDR, and IOP but used glaucoma medications). Survey weights were used in analyses.
Results: The glaucoma prevalence was 2.5% (95% confidence interval [CI] 1.7%-3.3%) utilizing self-reports, 3.0% (95% CI 2.1%-3.9%) by CDR ≥ 0.7 only and 10.3% (7.8%-12.8%) with failed FDT only. Merging test data, the prevalence of definite glaucoma was 0.7% (95% CI 0.3%-1.1%) and the prevalence of suspected glaucoma was 16.3% (95% CI 13.2%-19.4%). Among the patients suspected of having glaucoma, 44.4% had ocular hypertension (OHT, mean IOP 22.8 mmHg) and 6.8% used glaucoma medications. IOP ≥28 mmHg was found in 2.4% of OHT individuals, and none used glaucoma medications.37.5% of Canadians with definite glaucoma were unaware they had glaucoma.
Conclusions: Glaucoma prevalence in Canadians aged 40-79 varied between 0.7% and 10.3% depending on definition used. 16.3% of Canadians were labeled "glaucoma suspects". Nearly 40% of Canadians with definite glaucoma were unaware of having glaucoma.
{"title":"Prevalence of glaucoma in Canada: results from the 2016-2019 Canadian Health Measures Survey.","authors":"Ya-Ping Jin, Kiko Zi Yi Huang, Qingqing K Zhao, Graham E Trope, Yvonne M Buys, Sherif El-Defrawy, Peng Yan, Michael H Brent, Ziad Butty","doi":"10.1016/j.jcjo.2024.08.016","DOIUrl":"10.1016/j.jcjo.2024.08.016","url":null,"abstract":"<p><strong>Objective: </strong>To estimate the prevalence of glaucoma in Canada based on self-reports and test data, including Frequency Doubling Technology Perimetry (FDT), optic nerve vertical cup-to-disc ratio (CDR), intraocular pressure (IOP), and use of glaucoma medications.</p><p><strong>Design: </strong>Cross-sectional survey.</p><p><strong>Participants: </strong>2,600-4,100 participants aged 40-79 in the Canadian Health Measures Survey 2016-2019 with available information from self-report, CDR, FDT, and IOP.</p><p><strong>Methods: </strong>Glaucoma was defined by self-reports, CDR ≥ 0.7 only, or failed FDT only. Incorporating results of CDR, FDT, IOP, and use of glaucoma medications, participants were further classified as definite glaucoma (failed FDT and CDR ≥ 0.7) or glaucoma suspects (CDR ≥ 0.7 only, failed FDT only, or IOP > 21 mmHg only, or \"normal\" values of FDT, CDR, and IOP but used glaucoma medications). Survey weights were used in analyses.</p><p><strong>Results: </strong>The glaucoma prevalence was 2.5% (95% confidence interval [CI] 1.7%-3.3%) utilizing self-reports, 3.0% (95% CI 2.1%-3.9%) by CDR ≥ 0.7 only and 10.3% (7.8%-12.8%) with failed FDT only. Merging test data, the prevalence of definite glaucoma was 0.7% (95% CI 0.3%-1.1%) and the prevalence of suspected glaucoma was 16.3% (95% CI 13.2%-19.4%). Among the patients suspected of having glaucoma, 44.4% had ocular hypertension (OHT, mean IOP 22.8 mmHg) and 6.8% used glaucoma medications. IOP ≥28 mmHg was found in 2.4% of OHT individuals, and none used glaucoma medications.37.5% of Canadians with definite glaucoma were unaware they had glaucoma.</p><p><strong>Conclusions: </strong>Glaucoma prevalence in Canadians aged 40-79 varied between 0.7% and 10.3% depending on definition used. 16.3% of Canadians were labeled \"glaucoma suspects\". Nearly 40% of Canadians with definite glaucoma were unaware of having glaucoma.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-05DOI: 10.1016/j.jcjo.2024.08.010
Hoyoung Jung, Jean Oh, Kirk A J Stephenson, Aaron W Joe, Zaid N Mammo
Objective: To assess the effect of prompt engineering on the accuracy, comprehensiveness, readability, and empathy of large language model (LLM)-generated responses to patient questions regarding retinal disease.
Design: Prospective qualitative study.
Participants: Retina specialists, ChatGPT3.5, and GPT4.
Methods: Twenty common patient questions regarding 5 retinal conditions were inputted to ChatGPT3.5 and GPT4 as a stand-alone question or preceded by an optimized prompt (prompt A) or preceded by prompt A with specified limits to length and grade reading level (prompt B). Accuracy and comprehensiveness were graded by 3 retina specialists on a Likert scale from 1 to 5 (1: very poor to 5: very good). Readability of responses was assessed using Readable.com, an online readability tool.
Results: There were no significant differences between ChatGPT3.5 and GPT4 across any of the metrics tested. Median accuracy of responses to a stand-alone question, prompt A, and prompt B questions were 5.0, 5.0, and 4.0, respectively. Median comprehensiveness of responses to a stand-alone question, prompt A, and prompt B questions were 5.0, 5.0, and 4.0, respectively. The use of prompt B was associated with a lower accuracy and comprehensiveness than responses to stand-alone question or prompt A questions (p < 0.001). Average-grade reading level of responses across both LLMs were 13.45, 11.5, and 10.3 for a stand-alone question, prompt A, and prompt B questions, respectively (p < 0.001).
Conclusions: Prompt engineering can significantly improve readability of LLM-generated responses, although at the cost of reducing accuracy and comprehensiveness. Further study is needed to understand the utility and bioethical implications of LLMs as a patient educational resource.
目的评估提示工程对大语言模型(LLM)生成的患者视网膜疾病问题回复的准确性、全面性、可读性和共鸣性的影响:设计:前瞻性定性研究:视网膜专家、ChatGPT3.5 和 GPT4:向 ChatGPT3.5 和 GPT4 输入有关 5 种视网膜疾病的 20 个常见患者问题,这些问题可以是单独的问题,也可以在问题之前加上优化提示(提示 A),或者在提示 A 之前加上规定的长度限制和年级阅读水平(提示 B)。准确性和全面性由 3 位视网膜专家以 1-5 分的李克特量表进行评分(1 分:非常差,5 分:非常好)。回答的可读性使用在线可读性工具 Readable.com 进行评估:结果:ChatGPT3.5 和 GPT4 在所有测试指标上都没有明显差异。对独立问题、提示 A 和提示 B 问题的回答的准确性中位数分别为 5.0、5.0 和 4.0。对独立问题、提示 A 和提示 B 问题回答的全面性中位数分别为 5.0、5.0 和 4.0。与回答独立问题或提示语 A 问题相比,使用提示语 B 的准确性和全面性较低(p < 0.001)。对于独立问题、提示语 A 和提示语 B 问题,两个 LLM 答案的平均阅读水平分别为 13.45、11.5 和 10.3(p < 0.001):提示工程可以大大提高 LLM 生成的回答的可读性,但代价是降低了准确性和全面性。要了解 LLM 作为患者教育资源的实用性和生物伦理意义,还需要进一步研究。
{"title":"Prompt engineering with ChatGPT3.5 and GPT4 to improve patient education on retinal diseases.","authors":"Hoyoung Jung, Jean Oh, Kirk A J Stephenson, Aaron W Joe, Zaid N Mammo","doi":"10.1016/j.jcjo.2024.08.010","DOIUrl":"10.1016/j.jcjo.2024.08.010","url":null,"abstract":"<p><strong>Objective: </strong>To assess the effect of prompt engineering on the accuracy, comprehensiveness, readability, and empathy of large language model (LLM)-generated responses to patient questions regarding retinal disease.</p><p><strong>Design: </strong>Prospective qualitative study.</p><p><strong>Participants: </strong>Retina specialists, ChatGPT3.5, and GPT4.</p><p><strong>Methods: </strong>Twenty common patient questions regarding 5 retinal conditions were inputted to ChatGPT3.5 and GPT4 as a stand-alone question or preceded by an optimized prompt (prompt A) or preceded by prompt A with specified limits to length and grade reading level (prompt B). Accuracy and comprehensiveness were graded by 3 retina specialists on a Likert scale from 1 to 5 (1: very poor to 5: very good). Readability of responses was assessed using Readable.com, an online readability tool.</p><p><strong>Results: </strong>There were no significant differences between ChatGPT3.5 and GPT4 across any of the metrics tested. Median accuracy of responses to a stand-alone question, prompt A, and prompt B questions were 5.0, 5.0, and 4.0, respectively. Median comprehensiveness of responses to a stand-alone question, prompt A, and prompt B questions were 5.0, 5.0, and 4.0, respectively. The use of prompt B was associated with a lower accuracy and comprehensiveness than responses to stand-alone question or prompt A questions (p < 0.001). Average-grade reading level of responses across both LLMs were 13.45, 11.5, and 10.3 for a stand-alone question, prompt A, and prompt B questions, respectively (p < 0.001).</p><p><strong>Conclusions: </strong>Prompt engineering can significantly improve readability of LLM-generated responses, although at the cost of reducing accuracy and comprehensiveness. Further study is needed to understand the utility and bioethical implications of LLMs as a patient educational resource.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-05DOI: 10.1016/j.jcjo.2024.08.011
Saffire H Krance, Amin Hatamnejad, Rutmila Uddin, Sohel Somani, Eric Tam, Fahmeeda Murtaza, Hannah H Chiu
Objective: To quantify post-cataract surgery health care utilization caused by dry eye symptoms (DES) and identify preoperative risk factors and mediators of postoperative DES.
Setting: An outpatient surgical centre in Toronto, Canada.
Design: Retrospective cohort study.
Participants: Included patients had cataract surgery between April 2019 and January 2020, completed a preoperative Dry Eye Questionnaire 5 (DEQ5), and were over age 18.
Methods: Data collected included DES risk factors, prophylaxis, and intraoperative and postoperative details. DES health care utilization and prevalence were reported as percentages. Risk of DES follow-up with DES prophylaxis use, and within each DEQ5 severity group, were analyzed with χ2-square test of independence and odds ratios. Binomial logistic regression assessed for significance of multiple preoperative and intraoperative risk factors, controlling for one another.
Results: Of 1074 patients (46% male, mean age: 71, mean DEQ5: 5.12), 18.1% had at least one nonroutine postoperative appointment due to DES. Patients with moderate/severe DEQ5 scores were 1.843 times likelier to have postoperative DES concerns than those with no/mild scores (CI = 1.307-2.599). Preoperative DES prophylaxis did not reduce DES risk in any severity group. Higher DEQ5 score, female sex, bilateral sequential surgeries, and femtosecond laser-assisted cataract surgery had higher likelihood of postoperative DES (B = 0.054; p < 0.001; B = -0.351; p = 0.037; B = 0.695; p = 0.003; B = 0.491; p = 0.003, respectively).
Conclusion: Nearly 1 in 5 patients had DES postcataract surgery, with 1 in 12 requiring one or more nonroutine follow-ups for DES, suggesting substantial health care burden. Current standard preoperative DES treatment may not reduce postoperative DES, and further studies are needed to elucidate why.
目的量化白内障手术后因干眼症状(DES)引起的医疗费用使用情况,并确定术前风险因素和术后干眼症状的中介因素:背景:加拿大多伦多一家门诊手术中心:设计:回顾性队列研究:纳入的患者在 2019 年 4 月至 2020 年 1 月期间接受了白内障手术,完成了术前干眼症问卷 5 (DEQ5),且年龄在 18 岁以上:收集的数据包括 DES 风险因素、预防措施以及术中和术后详情。DES医疗利用率和患病率以百分比形式报告。采用χ2-square独立性检验和几率比分析了使用DES预防措施以及在每个DEQ5严重程度组别中DES随访的风险。二项式逻辑回归评估了术前和术中多种风险因素的重要性,并对这些因素进行了相互控制:在1074名患者中(46%为男性,平均年龄:71岁,平均DEQ5:5.12),18.1%的患者因DES至少有一次非例行术后预约。DEQ5中度/重度评分患者术后出现DES问题的可能性是无/轻度评分患者的1.843倍(CI = 1.307-2.599)。术前DES预防并不能降低任何严重程度组的DES风险。DEQ5评分较高、女性、双侧连续手术和飞秒激光辅助白内障手术患者术后发生DES的可能性较高(分别为B = 0.054; p < 0.001; B = -0.351; p = 0.037; B = 0.695; p = 0.003; B = 0.491; p = 0.003):结论:近五分之一的患者在白内障手术后接受了DES治疗,其中十二分之一的患者需要进行一次或多次DES非例行随访,这表明医疗负担沉重。目前标准的术前DES治疗可能无法减少术后DES的发生,需要进一步的研究来阐明原因。
{"title":"Health care utilization, prevalence, and risk factors of dry eyes after cataract surgery.","authors":"Saffire H Krance, Amin Hatamnejad, Rutmila Uddin, Sohel Somani, Eric Tam, Fahmeeda Murtaza, Hannah H Chiu","doi":"10.1016/j.jcjo.2024.08.011","DOIUrl":"10.1016/j.jcjo.2024.08.011","url":null,"abstract":"<p><strong>Objective: </strong>To quantify post-cataract surgery health care utilization caused by dry eye symptoms (DES) and identify preoperative risk factors and mediators of postoperative DES.</p><p><strong>Setting: </strong>An outpatient surgical centre in Toronto, Canada.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Participants: </strong>Included patients had cataract surgery between April 2019 and January 2020, completed a preoperative Dry Eye Questionnaire 5 (DEQ5), and were over age 18.</p><p><strong>Methods: </strong>Data collected included DES risk factors, prophylaxis, and intraoperative and postoperative details. DES health care utilization and prevalence were reported as percentages. Risk of DES follow-up with DES prophylaxis use, and within each DEQ5 severity group, were analyzed with χ<sup>2</sup>-square test of independence and odds ratios. Binomial logistic regression assessed for significance of multiple preoperative and intraoperative risk factors, controlling for one another.</p><p><strong>Results: </strong>Of 1074 patients (46% male, mean age: 71, mean DEQ5: 5.12), 18.1% had at least one nonroutine postoperative appointment due to DES. Patients with moderate/severe DEQ5 scores were 1.843 times likelier to have postoperative DES concerns than those with no/mild scores (CI = 1.307-2.599). Preoperative DES prophylaxis did not reduce DES risk in any severity group. Higher DEQ5 score, female sex, bilateral sequential surgeries, and femtosecond laser-assisted cataract surgery had higher likelihood of postoperative DES (B = 0.054; p < 0.001; B = -0.351; p = 0.037; B = 0.695; p = 0.003; B = 0.491; p = 0.003, respectively).</p><p><strong>Conclusion: </strong>Nearly 1 in 5 patients had DES postcataract surgery, with 1 in 12 requiring one or more nonroutine follow-ups for DES, suggesting substantial health care burden. Current standard preoperative DES treatment may not reduce postoperative DES, and further studies are needed to elucidate why.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-31DOI: 10.1016/j.jcjo.2024.08.002
Ryan S Huang, Andrew Mihalache, Marko M Popovic, Colyn Munn, Isabela Martins Melo, Aurora Pecaku, Lyna Kamintsky, Alon Friedman, David T Wong, Rajeev H Muni
Objective: To examine the association between quantitative vascular parameters extracted from intravenous fluorescein angiography (IVFA) and baseline clinical characteristics of patients with retinal vein occlusion (RVO).
Methods: Our prospective single-centre study in Toronto, Canada, recruited patients with a diagnosis of macular edema secondary to RVO presenting with a central macular thickness (CMT) ≥310 μm from 2017 to 2023. IVFA images were captured using an ultra-widefield scanning laser ophthalmoscope and processed using the artificial intelligence-based RETICAD system to extract quantitative measurements of blood flow, perfusion, and blood-retinal barrier (BRB) permeability. Univariable and multivariable regression models were used to investigate associations between quantitative IVFA parameters and baseline best-corrected visual acuity (BCVA), CMT, and macular volume.
Results: The study included 41 eyes from 41 RVO patients. In the multivariable analysis, BRB permeability was significantly associated with both CMT (p < 0.001) and macular volume (p = 0.005). Subgroup analyses revealed that in central RVO patients, central BRB permeability remained significantly associated with CMT (p = 0.022) and macular volume (p = 0.010); however, there was no association with BCVA (p = 0.921). In branch RVO patients, central BRB permeability was significantly associated with BCVA (p = 0.006) and CMT (p = 0.009), but not with macular volume (p = 0.723). Additionally, both central and peripheral BRB permeability were significantly higher in patients with RVO compared to healthy controls (p < 0.001).
Conclusions: Our investigation reveals novel associations between baseline clinical characteristics and quantitative IVFA parameters in RVO patients, which may serve as clinically relevant biomarkers. Future studies should explore these associations in diverse RVO patient populations with extended follow-up.
{"title":"Artificial intelligence-based extraction of quantitative ultra-widefield fluorescein angiography parameters in retinal vein occlusion.","authors":"Ryan S Huang, Andrew Mihalache, Marko M Popovic, Colyn Munn, Isabela Martins Melo, Aurora Pecaku, Lyna Kamintsky, Alon Friedman, David T Wong, Rajeev H Muni","doi":"10.1016/j.jcjo.2024.08.002","DOIUrl":"10.1016/j.jcjo.2024.08.002","url":null,"abstract":"<p><strong>Objective: </strong>To examine the association between quantitative vascular parameters extracted from intravenous fluorescein angiography (IVFA) and baseline clinical characteristics of patients with retinal vein occlusion (RVO).</p><p><strong>Methods: </strong>Our prospective single-centre study in Toronto, Canada, recruited patients with a diagnosis of macular edema secondary to RVO presenting with a central macular thickness (CMT) ≥310 μm from 2017 to 2023. IVFA images were captured using an ultra-widefield scanning laser ophthalmoscope and processed using the artificial intelligence-based RETICAD system to extract quantitative measurements of blood flow, perfusion, and blood-retinal barrier (BRB) permeability. Univariable and multivariable regression models were used to investigate associations between quantitative IVFA parameters and baseline best-corrected visual acuity (BCVA), CMT, and macular volume.</p><p><strong>Results: </strong>The study included 41 eyes from 41 RVO patients. In the multivariable analysis, BRB permeability was significantly associated with both CMT (p < 0.001) and macular volume (p = 0.005). Subgroup analyses revealed that in central RVO patients, central BRB permeability remained significantly associated with CMT (p = 0.022) and macular volume (p = 0.010); however, there was no association with BCVA (p = 0.921). In branch RVO patients, central BRB permeability was significantly associated with BCVA (p = 0.006) and CMT (p = 0.009), but not with macular volume (p = 0.723). Additionally, both central and peripheral BRB permeability were significantly higher in patients with RVO compared to healthy controls (p < 0.001).</p><p><strong>Conclusions: </strong>Our investigation reveals novel associations between baseline clinical characteristics and quantitative IVFA parameters in RVO patients, which may serve as clinically relevant biomarkers. Future studies should explore these associations in diverse RVO patient populations with extended follow-up.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142119078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-29DOI: 10.1016/j.jcjo.2024.08.007
Judith Kreminger, Johannes Iby, Stephanie Rokitansky, Heiko Stino, Michael Niederleithner, Thomas Schlegl, Wolfgang Drexler, Tilman Schmoll, Rainer Leitgeb, Andreas Pollreisz, Ursula Schmidt-Erfurth, Stefan Sacu
Objective: To investigate the localization, distribution, and type of central microaneurysms (MAs) and their relationship with retinal vascular alterations in patients with retinal vein occlusion (RVO).
Methods: In this cross-sectional study, ultra-widefield color fundus photography (UWF-CF), standard and single-capture 65° widefield (WF) optical coherence tomography angiography (OCTA) were performed in consecutive patients with RVO treated at the Department of Ophthalmology and Optometry, Medical University of Vienna. UWF-CF, en face and B-Scans in 6 mm × 6 mm OCTA were examined for detection of MAs. Nonperfusion areas (NPA) and collateral vessels (CV) were evaluated on WF-OCTA, ghost vessels (GV), and tortuous vessels (TV) on UWF-CF.
Results: One-hundred-and-twelve patients were included in the study, and data from 59 eyes of 59 patients with disease duration longer than 3 months, good image quality, and without relevant ocular comorbidities were eligible for statistical analysis. Fifty-six of 59 (94.9%) patients were previously treated with anti-vascular endothelial growth factor agents for macular edema, 31 of 59 (52.5%) patients presented with MAs in the central 6 mm and 60 MAs were found in total using multimodal imaging. There was no statistically significant difference in the greatest diameter of fluid-associated versus non-fluid-associated MAs (p = 0.53). Eyes with MAs were associated with CV, TV, and GV (χ2-test; p < 0.001, p = 0.0498, and p = 0.001). Median NPA was 27.3 mm2 (quartiles 1.3-62.8 mm2) in eyes with MAs and 0 mm2 (quartiles 0-36.2 mm2) in eyes without MAs (Mann-Whitney-U-test; p = 0.018).
Conclusion: MAs were associated with extensive NPA, the presence of CV, GV, and TV. There was no correlation between the diameter of the MA and the adjacent intraretinal fluid in our predominantly pretreated RVO study patients.
{"title":"Association of microaneurysms with retinal vascular alterations in patients with retinal vein occlusion.","authors":"Judith Kreminger, Johannes Iby, Stephanie Rokitansky, Heiko Stino, Michael Niederleithner, Thomas Schlegl, Wolfgang Drexler, Tilman Schmoll, Rainer Leitgeb, Andreas Pollreisz, Ursula Schmidt-Erfurth, Stefan Sacu","doi":"10.1016/j.jcjo.2024.08.007","DOIUrl":"10.1016/j.jcjo.2024.08.007","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the localization, distribution, and type of central microaneurysms (MAs) and their relationship with retinal vascular alterations in patients with retinal vein occlusion (RVO).</p><p><strong>Methods: </strong>In this cross-sectional study, ultra-widefield color fundus photography (UWF-CF), standard and single-capture 65° widefield (WF) optical coherence tomography angiography (OCTA) were performed in consecutive patients with RVO treated at the Department of Ophthalmology and Optometry, Medical University of Vienna. UWF-CF, en face and B-Scans in 6 mm × 6 mm OCTA were examined for detection of MAs. Nonperfusion areas (NPA) and collateral vessels (CV) were evaluated on WF-OCTA, ghost vessels (GV), and tortuous vessels (TV) on UWF-CF.</p><p><strong>Results: </strong>One-hundred-and-twelve patients were included in the study, and data from 59 eyes of 59 patients with disease duration longer than 3 months, good image quality, and without relevant ocular comorbidities were eligible for statistical analysis. Fifty-six of 59 (94.9%) patients were previously treated with anti-vascular endothelial growth factor agents for macular edema, 31 of 59 (52.5%) patients presented with MAs in the central 6 mm and 60 MAs were found in total using multimodal imaging. There was no statistically significant difference in the greatest diameter of fluid-associated versus non-fluid-associated MAs (p = 0.53). Eyes with MAs were associated with CV, TV, and GV (χ<sup>2</sup>-test; p < 0.001, p = 0.0498, and p = 0.001). Median NPA was 27.3 mm<sup>2</sup> (quartiles 1.3-62.8 mm<sup>2</sup>) in eyes with MAs and 0 mm<sup>2</sup> (quartiles 0-36.2 mm<sup>2</sup>) in eyes without MAs (Mann-Whitney-U-test; p = 0.018).</p><p><strong>Conclusion: </strong>MAs were associated with extensive NPA, the presence of CV, GV, and TV. There was no correlation between the diameter of the MA and the adjacent intraretinal fluid in our predominantly pretreated RVO study patients.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}